Career Enhancement Program

项目摘要/摘要 埃默里大学的肺癌孢子旨在促进早期职业肺癌的进展 调查人员通过实施职业提升计划(CEP)。拟议的肺脏的目标 癌症孢子CEP将为学术医生-科学家、临床医生-提供培训和指导- 希望致力于翻译研究的研究人员和实验室科学家 肺癌的诊断、成像、预防、治疗和改善生活质量的领域，以及 增强肺癌研究界的多样性。孢子CEP将建立在强大的 埃默里·温希普癌症研究所和相关医学院系对 初级调查员的职业发展，其中包括18名职业发展方案获奖者 埃默里以前的头颈癌孢子和正在进行的分子肿瘤学T32培训拨款。 拟议的CEP旨在提供一个环境，使有才华的早期职业调查人员能够从事 为期两年的指导研究计划，以促进他们的成功和学术生涯的发展 获得独立调查员地位的条件。CEP的具体目标如下：目标1：吸引 并指导一群才华横溢的早期职业研究人员从事转化性肺癌研究； 目标2：吸引埃默里大学的生物学家、科学家和医生以及当地合作伙伴进行研究 佐治亚州在转化型肺癌研究方面的机构；目标3：加强 肺癌研究社区，鼓励少数人、妇女和残疾人 申请CEP支持；目标4：促进和指导生物学研究的新战略， 肺癌的预防和长期治疗。平均每年将资助2个项目。其他内容 对CEP的支持已经从埃默里大学温希普癌症研究所的匹配资金中获得 医学院和伍德拉夫健康科学中心。

PROJECT SUMMARY/ABSTRACT Emory University’s Lung Cancer SPORE aims to promote the advancement of early career lung cancer investigators through the conduct of a Career Enhancement Program (CEP). The goals of the proposed Lung Cancer SPORE CEP are to provide training and guidance for academic physician-scientists, clinician- investigators, and laboratory-based scientists who wish to dedicate their efforts to translational research in the areas of diagnosis, imaging, prevention, treatment, and improvement in quality of life in lung cancer, and to enhance diversity among the lung cancer research community. The SPORE CEP will build on the strong commitment of the Emory Winship Cancer Institute and the associated School of Medicine Departments to the career development of junior investigators, which has included 18 career development program awardees as part of Emory’s previous head and neck cancer SPORE and an ongoing T32 training grant in molecular oncology. The proposed CEP aims to provide an environment that enables talented early career investigators to engage in a 2-year mentored research program and to facilitate their success and their academic career development in terms of achieving independent investigator status. Specific aims for the CEP are as follows: Aim 1: To attract and mentor a talented group of early career investigators towards a career in translational lung cancer research; Aim 2: To engage biologists, scientists and physicians present at Emory University and local partner research institutions in the state of Georgia in translational lung cancer research; Aim 3: To enhance diversity among the lung cancer research community by encouraging minority individuals, women, and individuals with disabilities to apply for CEP support; and Aim 4: To foster and guide emerging strategies for the study of the biology, prevention and long term treatment of lung cancer. On average, 2 projects will be funded annually. Additional support for the CEP has been secured from matching funds from the Winship Cancer Institute, Emory University School of Medicine and the Woodruff Health Sciences Center.